Chief Medical Officer of Kymera Therapeutics, Inc. (NASDAQ:KYMR), Gollob Jared, sells 6,499 shares worth $363,540
According to Kymera Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 07:27 PM, company Chief Medical Officer, Gollob Jared disclosed selling 6,499 shares at a cost of $55.94. At the time of this transaction (Feb 18), this trade was worth $363,540 in total. As of Feb 18, Gollob Jared now owns 93,498 shares in total worth about $5,112,470.64.
For the last few recent trades made by Kymera Therapeutics, Inc. (NASDAQ:KYMR) Chief Medical Officer, Gollob Jared, we have the following information:
- SEC Form 4 filing: Feb 17: Sold 7,550 shares at the rate of $58.39 per share. Total worth of this trade was $440,836. Total number of shares owned as of Feb 17 were 99,997
- SEC Form 4 filing: Feb 19: Sold 8,887 shares at the rate of $55.09 per share. Total worth of this trade was $489,559. Total number of shares owned as of Feb 19 were 84,611
Posted by
George Daniels
on Saturday February 20 2021, 7:27 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
